Nera Med - Company finances
|
EUR
|
2022
From: 2022-09-28
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | - | 545,901 | 438,513 | 364,566 |
| Profit before tax | -600 | 75,686 | -31,497 | 422 |
| Net profit | -600 | 63,648 | -31,497 | 332 |
| Equity | -566 | 63,148 | 9,651 | 9,984 |
| Liabilities | 600 | 43,194 | 23,855 | 14,875 |
| Non-current assets | 0 | 0 | 541 | 292 |
| Current assets | 34 | 106,342 | 32,965 | 24,567 |
| Total assets | 34 | 106,342 | 33,506 | 24,859 |
|
Taxes paid
|
||||
| STI taxes | - | - | 50,325 | 13,031 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | -19.7% | -16.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -1764.7% | 59.9% | -94.0% | 1.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 100.8% | -326.4% | 3.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 11.7% | -7.2% | 0.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 13.9% | -7.2% | 0.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.7 | 2.5 | 1.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 365,428 | 364,566 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Nera Med - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-01 | 2026-08-06 | 321.92 |
| 2026-07-01 | 2026-07-31 | 160.96 |
| 2026-06-02 | 2026-06-29 | 321.92 |
| 2026-05-03 | 2026-06-01 | 160.96 |
| 2026-04-01 | 2026-04-30 | 482.88 |
| 2026-03-03 | 2026-03-31 | 321.92 |
| 2026-02-03 | 2026-03-02 | 160.96 |
| 2026-01-08 | 2026-01-31 | 125.07 |
| 2026-01-01 | 2026-01-07 | 436.55 |
| 2025-12-02 | 2025-12-31 | 291.65 |
| 2025-11-01 | 2025-12-01 | 146.75 |
| 2025-10-23 | 2025-10-31 | 1.85 |
| 2025-10-01 | 2025-10-22 | 289.80 |
| 2025-09-02 | 2025-09-30 | 144.90 |
| 2025-08-19 | 2025-08-31 | 318.92 |
| 2025-08-01 | 2025-08-18 | 72.45 |
| 2025-07-16 | 2025-07-31 | 418.01 |
| 2025-07-01 | 2025-07-13 | 289.80 |
| 2025-06-17 | 2025-06-30 | 144.90 |
| 2025-06-11 | 2025-06-15 | 217.35 |
| 2025-06-08 | 2025-06-09 | 217.35 |
| 2025-06-03 | 2025-06-04 | 217.35 |
| 2025-05-16 | 2025-06-02 | 72.45 |
| 2025-05-04 | 2025-05-13 | 144.90 |
| 2025-04-01 | 2025-04-13 | 354.30 |
| 2025-03-28 | 2025-03-31 | 209.40 |
| 2025-03-18 | 2025-03-27 | 281.85 |
| 2025-03-04 | 2025-03-11 | 281.85 |
| 2025-03-03 | 2025-03-03 | 136.95 |
| 2025-03-01 | 2025-03-02 | 281.85 |
| 2025-02-21 | 2025-02-28 | 136.95 |
| 2025-02-18 | 2025-02-20 | 209.40 |
| 2025-01-02 | 2025-01-07 | 64.50 |
| 2024-11-04 | 2024-11-10 | 64.50 |
| 2024-10-01 | 2024-10-06 | 387.00 |
| 2024-09-17 | 2024-09-30 | 322.50 |
Nera Med - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-09 | 2026-01-09 | 669.6 |
| 2026-01-08 | 2026-01-08 | 2337.22 |
| 2026-01-03 | 2026-01-07 | 7069.59 |
| 2025-12-31 | 2026-01-02 | 7306.59 |
| 2025-12-15 | 2025-12-30 | 7328.42 |
| 2025-12-12 | 2025-12-14 | 10654.32 |
| 2025-12-05 | 2025-12-11 | 10597.73 |
| 2025-11-15 | 2025-12-04 | 11079.93 |
| 2025-11-06 | 2025-11-14 | 11165.85 |
| 2025-11-02 | 2025-11-05 | 11073.32 |
| 2025-10-16 | 2025-11-01 | 11262.17 |
| 2025-09-16 | 2025-10-15 | 12078.32 |
| 2025-09-14 | 2025-09-15 | 12263.9 |
| 2025-09-13 | 2025-09-13 | 12260.08 |
| 2025-09-12 | 2025-09-12 | 16761.64 |
| 2025-09-11 | 2025-09-11 | 16754.94 |
| 2025-06-04 | 2025-06-17 | 1023.77 |
| 2025-05-31 | 2025-06-03 | 1073.11 |
| 2025-05-30 | 2025-05-30 | 2664.07 |
| 2025-05-29 | 2025-05-29 | 2663.36 |
| 2025-05-28 | 2025-05-28 | 2662.65 |
| 2025-05-24 | 2025-05-27 | 2879.15 |
| 2025-02-21 | 2025-02-21 | 3232.11 |
| 2025-02-20 | 2025-02-20 | 19181.76 |
| 2024-12-22 | 2024-12-28 | 2.76 |
| 2024-12-19 | 2024-12-20 | 2616.48 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Nera Med, MB (code 306152473) is a small partnership operating in other non-specialised retail sale. In the latest financial year 2025, the company generated revenue of €364.6K and recorded net profit of €332, which means performance was close to break-even after the difficult 2024 result. Revenue declined by 16.9% year on year and by 33.2% compared with 2023, showing a clear downward sales trend across the last three years. Profitability also weakened sharply from a net profit of €63.6K in 2023 to a net loss of €31.5K in 2024, before returning to a very small profit in 2025. The balance sheet remained compact, with total assets of €24.9K, equity of €10.0K and liabilities of €14.9K at the end of 2025. The company reported ROE of 3.3% and ROA of 1.3%, while debt-to-equity stood at 1.49 and asset turnover at 14.67x. Revenue per employee was €364.6K, while profit per employee was only €332, reflecting the very limited earnings level in 2025.